oa SA Pharmaceutical Journal - A review of new vaccines for the pharmacist : review

Volume 80, Issue 2
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Recently, four new vaccines were launched: Vivaxim®, Priorix-Tetra®, Boostrix Tetra® and RotaTeq®. Vivaxim® is an inactivated combined hepatitis A and typhoid polysaccharide vaccine. There is an overlap in the global distribution of hepatitis A and typhoid fever. Therefore, protection against both hepatitis A and typhoid fever is often recommended for travel to high-risk areas. Having one vaccine that protects against two diseases may improve compliance and uptake. Priorix-Tetra® is a live combined measles, mumps, rubella and varicella vaccine which may be used in place of the measles, mumps and rubella, and varicella vaccines. Again this reduces the number of injections that a child has to have. (It is unfortunately not yet available in the market and will be announced and reviewed in once it is available.). Boostrix Tetra® is an inactivated booster vaccine against diphtheria, tetanus, pertussis and polio. As pertussis immunity wanes within 5-10 years of the last dose, a pertussis booster in adulthood is of the utmost importance, especially when the adult is in contact with young infants. RotaTeq® is a live oral pentavalent vaccine. It is given as part of the routine childhood immunisation schedule to protect infants from rotavirus gastroenteritis.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error